Source: Investing.com ↗

Barclays upgrades Alvotech stock rating on FDA approval outlook

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$86,136.01

+0.79%

ETH/USDT

$2,741.49

+0.41%

ZEC/USDT

$1,621.80

+6.93%

XRP/USDT

$1.61

+5.90%